Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

Robert A. Rosenheck, Douglas L. Leslie, Jody Sindelar, Edward A. Miller, Haiqun Lin, T. Scott Stroup, Joseph Patrick McEvoy, Sonia M. Davis, Richard S.E. Keefe, Marvin Swartz, Diana O. Perkins, John K. Hsiao, Jeffrey Lieberman

Research output: Contribution to journalArticlepeer-review

240 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences